Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
colon cancer associated transcript 2 | 0.621 | 0.615 |
|
disease | 0.100 | None | 1.000 | 14 | 3 | 2007 | 2019 | |||||||||
|
colon cancer associated transcript 2 | 0.621 | 0.615 |
|
disease | 0.100 | None | 1.000 | 14 | 3 | 2007 | 2019 | |||||||||
|
colon cancer associated transcript 2 | 0.621 | 0.615 |
|
disease | 0.100 | None | 1.000 | 14 | 3 | 2007 | 2019 | |||||||||
|
colon cancer associated transcript 2 | 0.621 | 0.615 |
|
disease | 0.100 | None | 1.000 | 14 | 3 | 2007 | 2019 | |||||||||
|
colon cancer associated transcript 2 | 0.621 | 0.615 |
|
phenotype | 0.100 | None | 1.000 | 14 | 3 | 2007 | 2019 | |||||||||
|
colon cancer associated transcript 2 | 0.621 | 0.615 |
|
disease | 0.100 | None | 1.000 | 14 | 3 | 2007 | 2019 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.100 | None | 1.000 | 14 | 7 | 2007 | 2019 | |||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
disease | 0.200 | None | 1.000 | 12 | 8 | 2007 | 2020 | |||||||||
|
HNF1A antisense RNA 1 | 0.621 | 0.538 |
|
phenotype | 0.100 | None | 1.000 | 10 | 4 | 2009 | 2019 | |||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
disease | 0.200 | None | 0.978 | 9 | 8 | 2007 | 2019 | |||||||||
|
RTEL1-TNFRSF6B readthrough (NMD candidate) | 0.682 | 0.385 |
|
disease | 0.100 | None | 1.000 | 9 | 4 | 2009 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 1470 | 0.890 | 0.077 |
|
disease | 0.100 | None | 1.000 | 9 | 8 | 2013 | 2019 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
phenotype | 0.200 | None | 0.958 | 9 | 9 | 2005 | 2019 | |||||||||
|
colorectal cancer associated 1 | 0.780 | 0.154 |
|
disease | 0.110 | None | 1.000 | 9 | 2 | 2008 | 2019 | |||||||||
|
colorectal cancer associated 1 | 0.780 | 0.154 |
|
disease | 0.130 | None | 1.000 | 9 | 2 | 2008 | 2019 | |||||||||
|
colorectal cancer associated 1 | 0.780 | 0.154 |
|
group | 0.100 | None | 1.000 | 9 | 2 | 2008 | 2019 | |||||||||
|
colorectal cancer associated 1 | 0.780 | 0.154 |
|
disease | 0.100 | None | 1.000 | 9 | 2 | 2008 | 2019 | |||||||||
|
colorectal cancer associated 1 | 0.780 | 0.154 |
|
disease | 0.100 | None | 1.000 | 9 | 2 | 2008 | 2019 | |||||||||
|
colorectal cancer associated 1 | 0.780 | 0.154 |
|
disease | 0.100 | None | 1.000 | 9 | 2 | 2008 | 2019 | |||||||||
|
colorectal cancer associated 1 | 0.780 | 0.154 |
|
disease | 0.100 | None | 1.000 | 9 | 2 | 2008 | 2019 | |||||||||
|
colorectal cancer associated 1 | 0.780 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 9 | 2 | 2008 | 2019 | |||||||||
|
colorectal cancer associated 1 | 0.780 | 0.154 |
|
disease | 0.100 | None | 1.000 | 9 | 2 | 2008 | 2019 | |||||||||
|
MIR137 host gene | 0.839 | 0.038 |
|
disease | 0.460 | None | 0.500 | 9 | 6 | 2011 | 2019 | |||||||||
|
HHIP antisense RNA 1 | 1.000 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 9 | 5 | 2008 | 2019 | |||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
disease | 0.430 | None | 1.000 | 8 | 9 | 2011 | 2018 |